PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative

Grigore Aristide Gafencu, Ciprian Ionuț Tomuleasa, Gabriel Ghiaur

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative'. Together they form a unique fingerprint.

Medicine & Life Sciences